<?xml version="1.0" encoding="UTF-8"?><meta xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns="http://www.w3.org/1999/xhtml" xmlns:xi="http://www.w3.org/2001/XInclude" http-equiv="Content-Type" content="text/html; charset=utf-8" />
<style xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:xi="http://www.w3.org/2001/XInclude" type="text/css">
   @media screen{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .tds_obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:95%
   }
   .test-story-main table tbody tr td{
   font-size: 110%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   font-size:100%;
   }
   .test-story-main fieldset{
   text-align:center;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   
   }
   .test-story-main table th{
   border:2px groove;
   
   }
   .test-story-main table td{
   border:1px groove;
   
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:center;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .title{
   text-align:left;
   }
   .test-story-main h3{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .pgBrk{
   padding-top:15px;
   }
   .test-story-main .er7Msg{
   width:100%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
   
   @media print{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:90%
   }
   .test-story-main table tbody tr td{
   font-size:90%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   
   }
   .test-story-main table thead tr th{
   text-align:center;
   background:#4682B4;
   
   }
   .test-story-main fieldset{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   page-break-inside:avoid;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   }
   .test-story-main table th{
   border:2px groove;
   }
   .test-story-main table td{
   border:1px groove;
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:left;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left;
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .tds_title{
   text-align:left;
   margin-bottom:1%
   }
   .test-story-main h3{
   text-align:center;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .tds_pgBrk{
   page-break-after:always;
   }
   .test-story-main #er7Message table{
   border:0px;
   width:80%
   }
   .test-story-main #er7Message td{
   background:#B8B8B8;
   font-size:65%;
   margin-top:6.0pt;
   border:0px;
   text-wrap:preserve-breaks;
   white-space:pre;
   }
   .test-story-main .er7Msg{
   width:100%;
   font-size:80%;
   }
   .test-story-main .er7MsgNote{
   width:100%;
   font-style:italic;
   font-size:80%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .embSubSpace{
   padding-left:25px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
</style>
<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
<fieldset>
	<div class="test-story-main">
		<tabset>
			<tab heading="FULL"  vertical="false">
				<div class="panel-body">
					<div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The SUT shall be required to capture the respective vaccine program applicable to the vaccine administered.<br><br>Various jurisdictions are establishing new programs to provide vaccines and their administration to defined patient population for some or all vaccines. &nbsp;Many are juridiction specific programs. &nbsp;<br><br>For context, the Immunization standard 2.5.1 uses OBX-5 to specify the client eligibility for a funding program and the dose administered level. Table 0064 lists available codes as V01 Not VFC eligible, V02 VFC eligible-Medicaid/Medicaid Managed Care, V03 VFC eligible Uninsured, V04 VFC eligible American Indian/Alaskan Native, VFC eligible-Federally Qualified Health Center (underinsured), V07 Local-specific eligibility. The extension of the Financial Class code set supports local vaccine program eligibility - IIP024- Emergent Tick Borne Illness Vaccine Program<br><br></p><p><br></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>Supports steps 7.1.1, 7.1.2, 7.1.4 and 7.1.5</p><p><br></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>No existing inventory codes contain a financial class of IIP024<br><br></p><p><br></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The entered vaccine includes a reference to the specific program that represents HL7 financial class IIP0024<br><br></p><p>Go to step 3.1.1</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p>To test the ability that the SUT can manage new program eligibility codes as they become available</p><p><br>Add Jurisdiction-Specific Vaccine Eligibility Code: The SUT demonstrates the ability to manage/add new program eligibility codes as they become available and to configure dose-level vaccine eligibility codes per jurisdictional requirements.<br><br></p><p><br></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>Financial class-specific eligibility program (Vaccine Eligibility) IIP024 exists post entry</p><p><br>1. Local user adds vaccine program to SUT</p><p><br>OR</p><p><br>2. SUT vendor enters vaccine program for users<br><br><br></p><table border="0" cellpadding="0" cellspacing="0" width="555"><tbody><tr height="20"><td height="20" width="303">Code</td><td width="252">Label/Description</td></tr><tr height="20"><td height="20" width="303">IIP024</td><td width="252">HeartlandVV-Program</td></tr></tbody></table><p><br></p><p><strong>If a new vaccine program cannot be added dynamically, it should be added via the process originally attested to prior to the day of testing.<br>Previously Attested to: (a) Process for adding new program, (b) time it takes to add new program</strong></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p><strong>Vaccine Eligibility /VFC (Vaccines for Children) Eligibility (financial class)</strong> refers to the criteria that determine whether an individual qualifies to receive a specific vaccine at a given time. Some patient specific factors in determining eligibility are age, insurance, income level, community risk/outbreak, and health condition.</p><p><strong>Vaccine Funding Source&nbsp;</strong>refers to the inventory location that the vaccine was taken from and is determined by the financial mechanism or program that covers the cost of the vaccine. If the vaccine was privately purchased and not received via any government program, then the funding source selection should be Private. If the vaccine was supplied via a government program, the funding source is Public. Some jurisdictions will have additional public funding sources such as Public non-VFC or Pandemic. Please check with the jurisdiction for funding source options. Please note: the eligibility of the patient doesn&#39;t always determine the funding source. A patient may not be eligible for a specific program but may still receive vaccine via a government program as was the case with the Covid vaccine. Example of this would be patient is Not VFC Eligible but the funding source would be Pandemic.<br><br></p></td></tr></table></div><br/>
				</div>
			</tab>
			<tab heading="Description" vertical="false"><div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The SUT shall be required to capture the respective vaccine program applicable to the vaccine administered.<br><br>Various jurisdictions are establishing new programs to provide vaccines and their administration to defined patient population for some or all vaccines. &nbsp;Many are juridiction specific programs. &nbsp;<br><br>For context, the Immunization standard 2.5.1 uses OBX-5 to specify the client eligibility for a funding program and the dose administered level. Table 0064 lists available codes as V01 Not VFC eligible, V02 VFC eligible-Medicaid/Medicaid Managed Care, V03 VFC eligible Uninsured, V04 VFC eligible American Indian/Alaskan Native, VFC eligible-Federally Qualified Health Center (underinsured), V07 Local-specific eligibility. The extension of the Financial Class code set supports local vaccine program eligibility - IIP024- Emergent Tick Borne Illness Vaccine Program<br><br></p><p><br></p></td></tr></table></div></tab><tab heading="Comments" vertical="false"><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>Supports steps 7.1.1, 7.1.2, 7.1.4 and 7.1.5</p><p><br></p></td></tr></table></div></tab><tab heading="Pre-condition" vertical="false"><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>No existing inventory codes contain a financial class of IIP024<br><br></p><p><br></p></td></tr></table></div></tab><tab heading="Post-Condition" vertical="false"><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The entered vaccine includes a reference to the specific program that represents HL7 financial class IIP0024<br><br></p><p>Go to step 3.1.1</p></td></tr></table></div></tab><tab heading="Test Objectives" vertical="false"><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p>To test the ability that the SUT can manage new program eligibility codes as they become available</p><p><br>Add Jurisdiction-Specific Vaccine Eligibility Code: The SUT demonstrates the ability to manage/add new program eligibility codes as they become available and to configure dose-level vaccine eligibility codes per jurisdictional requirements.<br><br></p><p><br></p></td></tr></table></div></tab><tab heading="Evaluation Criteria" vertical="false"><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>Financial class-specific eligibility program (Vaccine Eligibility) IIP024 exists post entry</p><p><br>1. Local user adds vaccine program to SUT</p><p><br>OR</p><p><br>2. SUT vendor enters vaccine program for users<br><br><br></p><table border="0" cellpadding="0" cellspacing="0" width="555"><tbody><tr height="20"><td height="20" width="303">Code</td><td width="252">Label/Description</td></tr><tr height="20"><td height="20" width="303">IIP024</td><td width="252">HeartlandVV-Program</td></tr></tbody></table><p><br></p><p><strong>If a new vaccine program cannot be added dynamically, it should be added via the process originally attested to prior to the day of testing.<br>Previously Attested to: (a) Process for adding new program, (b) time it takes to add new program</strong></p></td></tr></table></div></tab><tab heading="Notes" vertical="false"><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p><strong>Vaccine Eligibility /VFC (Vaccines for Children) Eligibility (financial class)</strong> refers to the criteria that determine whether an individual qualifies to receive a specific vaccine at a given time. Some patient specific factors in determining eligibility are age, insurance, income level, community risk/outbreak, and health condition.</p><p><strong>Vaccine Funding Source&nbsp;</strong>refers to the inventory location that the vaccine was taken from and is determined by the financial mechanism or program that covers the cost of the vaccine. If the vaccine was privately purchased and not received via any government program, then the funding source selection should be Private. If the vaccine was supplied via a government program, the funding source is Public. Some jurisdictions will have additional public funding sources such as Public non-VFC or Pandemic. Please check with the jurisdiction for funding source options. Please note: the eligibility of the patient doesn&#39;t always determine the funding source. A patient may not be eligible for a specific program but may still receive vaccine via a government program as was the case with the Covid vaccine. Example of this would be patient is Not VFC Eligible but the funding source would be Pandemic.<br><br></p></td></tr></table></div></tab>
		</tabset>
	</div>
</fieldset>